Skip to main content

NIH Working Group

This is the trans-NIH Working Group that oversees the development, implementation, communication, and assessment of the Common Fund program.

Co-Chairs:

Co-Chairs are Institute or Center (IC) directors or IC senior staff who lead the Working Group and have the authority to approve major activities and funding actions.

  • Joni L. Rutter, Ph.D.
    Acting Director
    National Center for Advancing Translational Sciences (NCATS)
  • Dinah S. Singer, Ph.D.
    Director
    Division of Cancer Biology
    National Cancer Institute (NCI)

Leadership Team & Points of Contact:

Coordinators, Program Leaders, and Project Team Leaders serve as the day to day leadership for the program and the Working Group. Also included here are points of contact for areas of program management.

Working Group Coordinators:

  • T. Kevin Howcroft, Ph.D.
    Program Director
    Division of Cancer Biology
    Cancer Immunology and Hematology Branch
    National Cancer Institute (NCI)
  • Danilo A. Tagle, Ph.D.
    Associate Director for Special Initiatives
    National Center for Advancing Translational Sciences (NCATS)

Common Fund Program Leader:

  • Patricia (Trish) Labosky, Ph.D.
    Program Leader
    Division of Program Coordination, Planning, and Strategic Initiatives
    Office of the Director (OD)
    National Institutes of Health (NIH)

Points of Contact:

  • Angela Ambrosi, M.P.A.
    Business Operations and Analysis Contact
    Program/Management Analyst
    Office of Strategic Coordination
    Division of Program Coordination, Planning, and Strategic Initiatives
    Office of the Director (OD)
  • Sara Amolegbe, M.S.P.H
    Strategic Planning, Evaluation, and Communications Contact
    Health Science Policy Analyst
    Office of Strategic Coordination
    Division of Program Coordination, Planning, and Strategic Initiatives
    Office of the Director (OD)
  • Christine Happel, Ph.D.
    Program Officer
    National Center for Advancing Translational Sciences (NCATS)

Members:

The Working Group Members are staff from multiple NIH Institutes and Centers who provide input from their Institute or Center’s perspective.

  • Alexandra Ainsztein, Ph.D.
    Program Director
    Division of Cell Biology and Biophysics
    National Institute of General Medical Sciences (NIGMS)
  • Preethi Chander, Ph.D.
    Program Director
    Salivary Biology and Immunology Program
    National Institute of Dental and Craniofacial Research (NIDCR)
  • Aniruddha Ganguly, Ph.D.
    Program Director
    Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis
    National Cancer Institute (NCI)
  • Daniel Gossett, Ph.D.
    Program Director
    Division of Kidney, Urologic, and Hematologic Diseases
    National Institute of Diabetes and Digestive and Kidney Diseases
  • Max Guo, Ph.D.
    Chief, Genetics and Cell Biology Branch
    Division of Aging Biology
    National Institute on Aging (NIA)
  • Nic Johnston, M.S.
    Scientific Program Analyst
    National Institute on Drug Abuse (NIDA)
  • Lillian S. Kuo, Ph.D.
    Program Director
    Division of Cancer Biology
    National Cancer Institute (NCI)
  • Tania B. Lombo, Ph.D.
    Program Officer
    Environmental Influences on Child Health Outcomes (ECHO)
    Office of the Director (OD)
    National Institutes of Health (NIH)
  • George A. McKie, D.V.M., Ph.D.
    Program Director
    Ocular Infection, Inflammation, and Immunology
    National Eye Institute (NEI)
  • Margaret Ochocinska, Ph.D.
    Program Director
    Translational Blood Science and Resources Branch
    Division of Blood Diseases and Resources
    National Heart, Lung, and Blood Institute (NHLBI)
  • Daniel Shaughnessy, Ph.D.
    Health Science Administrator
    Exposure, Response, and Technology Branch
    Division of Extramural Research and Training 
    National Institute of Environmental Health Sciences (NIEHS)
  • Dobrila (Doda) Rudnicki, Ph.D.
    Program Officer
    National Center for Advancing Translational Science (NCATS)
  • Anna Sadusky, Ph.D.
    Program Officer
    Division of Kidney, Urologic and Hematologic Diseases (KUH)
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • John Satterlee, Ph.D.
    Program Director
    Epigenetics, Model Organism Genetics, Functional Genomics
    National Institute on Drug Abuse (NIDA)
  • Shurjo K. Sen, Ph.D.
    Program Director
    Division of Genome Sciences
    National Human Genome Research Institute (NHGRI)
  • Jessica Smith, Ph.D.
    Scientific Review Officer
    Cell Biology Integrated Review Group
    Center for Scientific Review (CSR)
  • Pothur R. Srinivas, Ph.D., M.P.H.
    Program Director
    Division of Cardiovascular Sciences
    National Heart, Lung, and Blood Institute (NHLBI)

This page last reviewed on March 14, 2024